HealthMatch raises $7M Series C funding to help expand access and diversify clinical trials
The Driver: HealthMatch, an Australian startup focusing on matching patients with experimental drugs being studied in clinical trials of new therapies, recently raised $7M in Series C funding. The round was led by Folklore Ventures and joined by existing investor Square Peg Capital (who led their Series B round). HealthMatch will use the funding to increase staffing (following layoffs earlier this year) and to broaden services in the U.S. Key Takeaways: There are over 135,000